News & Updates in Obesity Medicine

Articles and resources to help you keep up to date on the latest research in obesity medicine

RETATRUTIDE

Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial

SEMAGLUTIDE

Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity

TIRZEPATIDE

Tirzepatide Once Weekly for the Treatment of Obesity

Upcoming Events in Obesity

  • ObesityWeek

    October 14-17, 2024

  • American Diabetes Association 84th Scientific Sessions

    June 21-24, 2024

  • Endocrine Society

    June 1-4, 2024

  • World Obesity Day

    March 4, 2024